A largely hidden flow of money between major consulting firms and PBMs compromises the firms' ability to choose drug benefits for employers.
Eros Dervishi for STAT 'It's beyond unethical': Opaque conflicts of interest permeate prescription drug benefits Employers across the country pay consulting firms to handle a straightforward task with their prescription drug coverage: Get the best deals possible, and make sure the industry's middlemen aren't ripping them off with unfair contracts. But a largely hidden flow of money between major consulting conglomerates and PBMs compromises that relationship, a STAT investigation shows. Read more. By Bob Herman |
|
Caroline Yang for STAT Scientists successfully unfroze rat organs and transplanted them — a 'historic' step that could someday transform transplant medicine It's the first time scientists have shown it's possible to successfully and repeatedly transplant a life-sustaining mammalian organ after it has been rewarmed from an icy metabolic arrest. Outside experts unequivocally called the results a seminal milestone for the field of organ preservation. Read more. By Marion Renault Molly Ferguson for STAT 'Falling through the cracks': Why ADHD is under-diagnosed among Asian Americans Medical knowledge of ADHD has advanced rapidly over the past decade, taking it from a label applied to unruly schoolboys and often used as shorthand for misbehavior, to a condition recognized as a neurodevelopmental disorder with clear biological underpinnings. Amid that sea change, though, people of color have all too often been left behind. Read more. By Olivia Goldhill More great reads from STAT this week |
|
Check out more exclusive coverage with a STAT+ subscription | Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles. |
|
| STAT, 1 Exchange Place, Boston, MA | ©2023, All Rights Reserved. | |
|
No comments